[1]
2024. Risk factors of doxorubicin-induced cardiomyopathy in non-muscle- invasive bladder cancer. Universa Medicina. 43, 3 (Nov. 2024), 297–303. DOI:https://doi.org/10.18051/UnivMed.2024.v43.297-303.